Article: Sanofi-aventis Statement.

PARIS, June 3 /PRNewswire-FirstCall/ -- During the Shareholders Meeting of sanofi-aventis held May 31, 2005, the Chairman and Chief Executive Officer, Mr. Jean-Francois Dehecq, responding to several written questions on behalf of the Board of Directors discussed sanofi-aventis's position with regard to Rhodia.

Mr. Jean-Francois Dehecq stated that he had already indicated that "Rhodia is not a strategic investment for sanofi-aventis and as a result, sanofi- aventis does not intend to sit on Rhodia's board of directors."

The company would like to point out that starting with Sanofi-Synthelabo's offering document for the Aventis tender offer in early ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!